Your Catalyst To a Lucrative Business
The worldwide industry is segmented on the basis of technologies , applications , and regions . Based on technologies , the Ablation Technology Market is divided into radiofrequency , ultrasound , electrical , and radiation . Due to widespread scope in cancer diagnosis , radiation technology led the global market in 2013 . Other factors that may positively impact this segment in the forthcoming years are availability of different types of radiation devices and high incidence of cancer . The segment for electrical ablation may expand robustly over the forecast period . This attributes to rising prevalence of cardiovascular disorders , such as atrial fibrillation .
Ablation technologies are predominantly applied in orthopedics , ophthalmology , cardiovascular procedures , and in cancer . Use of ablation technologies in cancer diagnosis generated the highest revenues in 2013 . Growing awareness about the popularity of ablation technology in cancer treatment is projected to fuel overall market demand . Cardiovascular applications are expected to increase considerably over the forecast period .
Geographically , the global ablation technology market is fragmented into Europe , Asia Pacific , North America , and Rest of the World . North America held highest shares in the overall industry back in 2013 . Awareness about ablation technologies and large number of people suffering from chronic diseases are key regional drivers . Ongoing industry trends suggest that Asia Pacific may expand remarkably in the years to come . The region is essentially propelled by surging healthcare expenditure and application of ablation technologies in diagnostics solutions . Growing preference for ablation over surgeries and substantial government spending on ablation technology could further contribute to regional demand .
Key companies operating the worldwide market are Boston Scientific Corporation , Olympus Corporation , AngioDynamics Inc ., Medtronic Inc ., and AtriCulture Inc . among others . Most industry participants focus greatly on innovations that aim at enhancing accuracy & efficiency of test results . Researchers have developed a cryoablation system that can attain much cooler temperatures than most conventional cryoablation technologies .
The new system can effectively create transmural ventricular lesions from the epicardium as well as the endocardium . It may prove beneficial for catheter-based & surgical ventricular tachycardia ablations in humans . This cryoablation technology utilizes liquid nitrogen and achieves temperatures as low as minus 160 degrees Celsius . This IceSense cryoablation system helps debulk tumors in lungs , kidneys , liver , and breast . It comprises a freezing element and a rigid probe that has a sharp needle tip .
Browse Related Category Market Reports @ https :// www . hexaresearch . com / research-category / medicaldevices-industry
Follow Us :